Select a clean injection site on your abdomen or thigh
Functionalized polyhydroxyalkanoate nano-beads as a stable biocatalyst for cost-effective production of the rare sugar d-allulose
Note that this does not necessarily mean that the problem is related to excess cortisol production like Cushings Syndrome
In the Lira Pump study, they decreased basal insulin by 10%, but increased bolus by 15% ( Our current practice is to consider a ~20% bolus insulin decrease and a ~10% basal insulin decrease before GLP-1RA initiation, although prior A1c, risk of hypoglycemia, potential risk of ketosis due to reduced insulin doses, as well as other patient-specific factors should guide the final insulin dose changes
Safety and Side Effects Like all GLP-1 medications, both liraglutide and semaglutide can cause some gastrointestinal distress including nausea, diarrhea, vomiting, reflux and constipation